EQS-News

Life Sciences Public Companies Present at the June 24 and 25 Life Sciences Virtual Investor Forum, Co-Hosted by Zacks Small-Cap Research 18.06.2026, 02:37 Uhr von EQS News Jetzt kommentieren: 0

EQS-News: B2i Digital, Inc. / Key word(s): Financial
Life Sciences Public Companies Present at the June 24 and 25 Life Sciences Virtual Investor Forum, Co-Hosted by Zacks Small-Cap Research

18.06.2026 / 02:37 CET/CEST
The issuer is solely responsible for the content of this announcement.


Two Days of Presentations Across Biotechnology, Diagnostics, Medical Devices, and Digital Health

 Direct Access to Management Teams Through Live Presentations, Real-Time Q&A, and One-on-One Meetings

NEW YORK, NY - June 17, 2026 (NEWMEDIAWIRE) - B2i Digital, Inc. invites investors to the Life Sciences Virtual Investor Forum, a B2i Digital Featured Conference, taking place over two days on June 24 and 25, 2026, and co-hosted by Virtual Investor Conferences and Zacks Small-Cap Research. 

6a333580da846f464b663369_1

B2i Digital, as the Official Marketing Partner, brings the forum into its ecosystem, anchored by a powerful distribution and media engine that drives qualified investors to the presentations and the one-on-one meetings that follow. Before, during, and after the two days, B2i amplifies the event across its platform, putting these life sciences companies in front of a proprietary network of more than 1.7 million retail and institutional market participants. The same visibility engine has carried more than 115 investor conferences. From Marketing to Meetings℠.

Zacks Small-Cap Research, a preferred provider in the OTC Markets Group's Research Marketplace, prepares independent company-sponsored research and related content for distribution across investor and media channels. Its team of life sciences analysts supports the forum as co-host.

The two-day lineup spans clinical-stage biotechnology, rare-disease and oncology therapeutics, molecular diagnostics, medical devices, veterinary medicine, nutrition science, and AI-powered digital health.

Each company has 30 minutes for a live presentation and Q&A. One-on-one meeting requests are available through the VIC site, with replays available on B2i Digital and OTC Markets YouTube channels.

“Life sciences investors want efficient, direct access to management teams developing the therapies and technologies that matter and pairing that access with independent research from Zacks makes the forum more valuable on both sides. Over two days, investors can meet companies across biotech, diagnostics, devices, and digital health, and reach their own conclusions,” said David Shapiro, Chief Executive Officer of B2i Digital.

To request one-on-one meetings with management: https://app.axleaccess.com/public/events/636943bb-55cb-4a39-81b5-f658175de392?token=7b91921e-7b44-4da7-be93-ea5c37a5ed76

For more details: https://b2idigital.com/vic-june-25th-life-sciences-virtual-investor-forum

Presenting Companies as of June 17, 2026 (subject to change): 

Day One – Wednesday, June 24 
9:30 AM ET: Protalix BioTherapeutics, Inc.
10:30 AM ET: MetaVia Inc.
11:30 AM ET: CytoSorbents Corporation
12:00 PM ET: PetVivo Holdings Inc.
1:00 PM ET: Jaguar Health, Inc.
1:30 PM ET: Reviva Pharmaceuticals Holdings, Inc.
3:00 PM ET: 4DMedical Ltd.

Day Two – Thursday, June 25 
9:30 AM ET: Prostatype Genomics AB
10:00 AM ET: Abingdon Health plc
10:30 AM ET: Innovotech, Inc.
11:00 AM ET: Lakewood-Amedex Biotherapeutics Inc.
11:00 AM ET: Nasus Pharma Ltd.
11:30 AM ET: Kelyniam Global, Inc.
12:00 PM ET: IMUNON, Inc.
12:30 PM ET: Promino Nutritional Sciences Inc.
1:00 PM ET: Envoy Medical Inc.
1:30 PM ET: Coiled Therapeutics plc
2:00 PM ET: Aspire Biopharma Holdings Inc.
2:30 PM ET: Rocket Doctor AI Inc.
3:00 PM ET: Phio Pharmaceuticals Corp.
3:30 PM ET: aTyr Pharma, Inc.
4:00 PM ET: NuFarm Ltd. 

For registration and company profiles, please visit: https://www.virtualinvestorconferences.com/wcc/eh/4814904/category/149532/june-24th-25th-life-sciences-virtual-investor-forum?utm_source=b2i&utm_medium=marketing&utm_campaign=0624LifeSciencesForumVIC 

Throughout the year, Virtual Investor Conferences feature public companies from exchanges worldwide, including NYSE, Nasdaq, TSX, TSXV, CSE, ASX, LSE, and the OTC Markets. Virtual Investor Conferences is an OTC Markets Group Inc. property.

About B2i Digital, Inc.

B2i Digital, Inc. partners with investor conferences, public companies, and capital markets advisors through its Featured Conference, Featured Company, and Featured Expert programs. Acting as The Capital Markets Matchmaker℠, B2i Digital connects investors and companies through digital marketing, investor conferences, and direct meetings, supported by a proprietary network of more than 1.7 million market participants and a track record as the marketing partner for over 115 investor conferences. Its mantra, From Marketing to Meetings℠, reflects this integrated approach. The firm was founded in 2021 by David Shapiro, a former Maxim Group investment banker and Chief Marketing Officer.

B2i Digital Contact Information
David Shapiro
Chief Executive Officer
B2i Digital, Inc.
https://b2idigital.com
212.579.4844 Office
david@b2idigital.com
https://www.linkedin.com/in/davidshapironyc

B2i Digital Social Media
https://www.linkedin.com/company/b2i-digital
https://x.com/b2idigital
https://www.facebook.com/b2idigital
https://www.instagram.com/b2i_digital
https://www.youtube.com/@b2idigital
https://www.tiktok.com/@b2idigital
https://stocktwits.com/B2iDigital
https://www.reddit.com/user/b2idigital/
https://www.pinterest.com/b2idigital
https://www.threads.net/@davidshapironyc
https://bsky.app/profile/b2idigital.bsky.social

About Zacks Small-Cap Research

Zacks Small-Cap Research is a preferred provider in the OTC Markets Group's Research Marketplace, preparing independent company-sponsored research and related content for distribution through a range of investor and media channels, both traditional and social. Its team of life sciences-qualified analysts develops in-depth company research aimed at building awareness among long-term investors.

Zacks Small-Cap Research Contact Information
Richard Hantke
Zacks Small-Cap Research
312.265.9448
rhantke@zacks.com
https://scr.zacks.com

About Virtual Investor Conferences

Virtual Investor Conferences is the proprietary investor conference series that provides an interactive forum for publicly traded companies to meet directly with investors online. VIC offers companies efficient access to a broad investor audience through live presentations, Q&A sessions, and one-on-one meetings. Investors benefit from direct access to executive management teams and the ability to view presentations live or on demand.

Virtual Investor Conferences Contact Information
Greg Young
VP Corporate Services
OTC Markets Group
(212) 652-5958
greg@otcmarkets.com

Disclosure & Disclaimer

B2i Digital, Inc. is the Official Marketing Partner of Virtual Investor Conferences. Content related to any specific company referenced in this release was provided by that company, approved by that company, or obtained from publicly available sources. B2i Digital, Inc. has not independently verified the accuracy or completeness of such information, and no representation or warranty, express or implied, is made as to its accuracy.

This content is provided for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security, nor should it be relied upon as the basis for any investment decision. B2i Digital, Inc. is not a registered broker-dealer, investment adviser, or financial adviser, and nothing herein should be construed as investment, legal, tax, or accounting advice. Readers should consult their own advisers and conduct their own due diligence before making any investment decision.

View the original release on www.newmediawire.com


News Source: B2i Digital, Inc.


18.06.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: B2i Digital, Inc.
United States
EQS News ID: 2348566

 
End of News EQS News Service

2348566  18.06.2026 CET/CEST

Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer